I agree that this site is using cookies. You can find further informations here.
X
SenGupta, Devi
109  results:
Search for persons X
?
1

Circulating immune and plasma biomarkers of time to HIV reb..:

Abdel-Mohsen, Mohamed ; Deeks, Steven ; Giron, Leila...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

HIV rebound in HIV controllers is associated with a specifi..:

Cai, Yanhui ; Podlaha, Ondrej ; Deeks, Steven G....
European Journal of Immunology.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Safety, immunogenicity and effect on viral rebound of HTI v..:

Bailón, Lucia ; Llano, Anuska ; Cedeño, Samandhy...
Nature Medicine.  28 (2022)  12 - p. 2611-2621 , 2022
Link: https://doi.org/10.1038/..
 
?
4

Multi-stakeholder consensus on a target product profile for..:

Lewin, Sharon R ; Attoye, Timothy ; Bansbach, Cathy...
The Lancet HIV.  8 (2021)  1 - p. e42-e50 , 2021
Link: https://doi.org/10.1016/..
 
?
5

557. Impact of Concomitant Hydroxychloroquine Use on Safety..:

Arribas, Jose Ramon ; Arribas, Jose Ramon ; Sanyal, Arun J...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S343-S344 , 2020
Link: https://doi.org/10.1093/..
 
?
6

73. Geographical Disparities in Clinical Outcomes of Severe..:

Diaz, George ; Arribas, Jose Ramon ; Arribas, Jose Ramon...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S167-S167 , 2020
Link: https://doi.org/10.1093/..
 
?
7

72. Remdesivir vs Standard Care in Patients with Moderate c..:

Marty, Francisco M ; Malhotra, Prashant ; Gottlieb, Robert L...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S166-S167 , 2020
Link: https://doi.org/10.1093/..
 
?
8

Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune..:

Riddler, Sharon A ; Para, Michael ; Benson, Constance A...
Clinical Infectious Diseases.  72 (2020)  11 - p. e815-e824 , 2020
Link: https://doi.org/10.1093/..
 
?
9

561. Safety of Remdesivir vs Standard Care in Patients with..:

Criner, Gerard J ; Criner, Gerard J ; Ahn, Mi Young...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S345-S346 , 2020
Link: https://doi.org/10.1093/..
 
?
10

548. Baseline characteristics associated with clinical impr..:

Castagna, Antonella ; Hui, David Shu Cheong ; Mullane, Kathleen M...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S340-S340 , 2020
Link: https://doi.org/10.1093/..
 
?
11

2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobic..:

Eron, Joseph J ; Lelievre, Jean-Daniel ; Kalayjian, Robert...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S864-S864 , 2019
Link: https://doi.org/10.1093/..
 
?
12

937. Virally Suppressed PLH Switching From Abacavir to Teno..:

Funderburg, Nicholas ; Mccomsey, Grace ; Kulkarni, Manjusha...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S34-S34 , 2018
Link: https://doi.org/10.1093/..
 
?
13

Correction: p16INK4a Expression and Immunologic Aging in Ch..:

Ribeiro, Susan Pereira ; Milush, Jeffrey M. ; Cunha-Neto, Edecio...
PLOS ONE.  12 (2017)  4 - p. e0176509 , 2017
Link: https://doi.org/10.1371/..
 
?
14

Coformulated bictegravir, emtricitabine, and tenofovir alaf..:

Sax, Paul E ; Pozniak, Anton ; Montes, M Luisa...
The Lancet.  390 (2017)  10107 - p. 2073-2082 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite ..:

de Mulder, Miguel ; SenGupta, Devi ; Deeks, Steven G....
Retrovirology.  14 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
1-15